Home
Market Capitalization of Vivo Bio Tech Ltd

Vivo Bio Tech Ltd
NSE: VIVOBIOTECH
Market Cap
Key Highlights
- The Market Cap of Vivo Bio Tech Ltd is ₹ 68.55 crore as of 17 Apr 25 .
- The Latest Trading Price of Vivo Bio Tech Ltd is ₹ 40.64 as of 17 Apr 15:30 .

Vivo Bio Tech Ltd
NSE: VIVOBIOTECH
Share Price
Market Price of Vivo Bio Tech Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
17 Apr 2025 | 40.64 |
16 Apr 2025 | 36.35 |
15 Apr 2025 | 35.68 |
11 Apr 2025 | 34.72 |
09 Apr 2025 | 34.89 |
08 Apr 2025 | 34.72 |
07 Apr 2025 | 34.2 |
04 Apr 2025 | 35.52 |
03 Apr 2025 | 36.88 |
02 Apr 2025 | 36.07 |
SWOT Analysis Of Vivo Bio Tech Ltd
BlinkX Score for Vivo Bio Tech Ltd
Asset Value vs Market Value of Vivo Bio Tech Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Vivo Bio Tech Ltd
Historical P/E Ratio of Vivo Bio Tech Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Vivo Bio Tech Ltd
Historical Revenue of Vivo Bio Tech Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Vivo Bio Tech Ltd
Historical EBITDA of Vivo Bio Tech Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Vivo Bio Tech Ltd
Historical Net Profit of Vivo Bio Tech Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Vivo Bio Tech Ltd
Dividend Payout Over Time
About Vivo Bio Tech Ltd
- Vivo Bio Tech Limited, established in February, 1987 is a full service CRO offering drug development & discovery services to pharmaceutical & biotech companies world-wide in accordance with OECD, AAALAC & IND guidelines.
- The company offers services in the areas of In vitro, In vivo, toxicity studies, pharmacological investigations, pharmacokinetics & toxicokinetic studies etc.
- Their experienced & talented scientists offer advice on defining drug development paths tailored to specific molecules. The Company stands as a premier and primary provider of SPF lab animals in India.
- It holds the distinction of being the largest breeder and distributor of rodent models, in addition to offering custom rodent models and stem cell products through Cyagen Biosciences.
- The Company serves as an authorized distributor of lab animal diets from Special Diets Services (UK) in India.
Vivo Bio Tech Ltd News Hub
Vivo Bio Tech consolidated net profit rises 21.43% in the June 2024 quarter
Net profit of Vivo Bio Tech rose 21.43% to Rs 0.17 crore in the quarter ended June 2024 as against R
Read more
12 Aug 24
Vivo Bio Tech announces board meeting date
Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 10 August 2024. Powere
Read more
02 Aug 24
Vivo Bio Tech to convene AGM
Vivo Bio Tech announced that the 37th Annual General Meeting (AGM) of the company will be held on 30
Read more
02 Sept 24
Vivo Bio Tech to hold board meeting
Vivo Bio Tech will hold a meeting of the Board of Directors of the Company on 14 November 2024 Power
Read more
30 Oct 24